1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Plasma Fractionation Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Plasma Fractionation Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising need for plasma-based treatments
- 5.1.2 Growing awareness of blood disorders
5.2 Market Opportunities
- 5.2.1 Expansion in the global healthcare market
- 5.2.2 Growth in blood plasma-based therapies
5.3 Future Trends
- 5.3.1 Advances in protein fractionation
- 5.3.2 Increase in the number of plasma-derived therapies
5.4 Impact of Drivers and Restraints
6. Europe Plasma Fractionation Market Regional Analysis
6.1 Europe Plasma Fractionation Market Overview
6.2 Europe Plasma Fractionation Market Revenue 2019-2028 (US$ Million)
6.3 Europe Plasma Fractionation Market Forecast Analysis
7. Europe Plasma Fractionation Market Analysis – by Product
7.1 Immunoglobulin
- 7.1.1 Overview
- 7.1.2 Immunoglobulin: Europe Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Albumin
- 7.2.1 Overview
- 7.2.2 Albumin: Europe Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Coagulation Factor Concentrates
- 7.3.1 Overview
- 7.3.2 Coagulation Factor Concentrates: Europe Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Protease Inhibitors
- 7.4.1 Overview
- 7.4.2 Protease Inhibitors: Europe Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Other Plasma Products
- 7.5.1 Overview
- 7.5.2 Other Plasma Products: Europe Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Plasma Fractionation Market Analysis – by Application
8.1 Neurology
- 8.1.1 Overview
- 8.1.2 Neurology: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Immunology
- 8.2.1 Overview
- 8.2.2 Immunology: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Hematology
- 8.3.1 Overview
- 8.3.2 Hematology: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Critical Care
- 8.4.1 Overview
- 8.4.2 Critical Care: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Pulmonology
- 8.5.1 Overview
- 8.5.2 Pulmonology: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Other Applications
- 8.6.1 Overview
- 8.6.2 Other Applications: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Plasma Fractionation Market Analysis – by End User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Other Applications: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Clinical Research Laboratories
- 9.2.1 Overview
- 9.2.2 Other Applications: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Academic Institutes
- 9.3.1 Overview
- 9.3.2 Other Applications: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Plasma Fractionation Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Plasma Fractionation Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 Europe Plasma Fractionation Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Plasma Fractionation Market Breakdown, by Product
- 10.1.1.1.2 UK: Europe Plasma Fractionation Market Breakdown, by Application
- 10.1.1.1.3 UK: Europe Plasma Fractionation Market Breakdown, by End User
- 10.1.1.2 Germany:
Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Plasma Fractionation Market Breakdown, by Product
- 10.1.1.2.2 Germany: Europe Plasma Fractionation Market Breakdown, by Application
- 10.1.1.2.3 Germany: Europe Plasma Fractionation Market Breakdown, by End User
- 10.1.1.3 France:
Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Plasma Fractionation Market Breakdown, by Product
- 10.1.1.3.2 France: Europe Plasma Fractionation Market Breakdown, by Application
- 10.1.1.3.3 France: Europe Plasma Fractionation Market Breakdown, by End User
- 10.1.1.4 Russia:
Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Plasma Fractionation Market Breakdown, by Product
- 10.1.1.4.2 Russia: Europe Plasma Fractionation Market Breakdown, by Application
- 10.1.1.4.3 Russia: Europe Plasma Fractionation Market Breakdown, by End User
- 10.1.1.5 Italy:
Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Plasma Fractionation Market Breakdown, by Product
- 10.1.1.5.2 Italy: Europe Plasma Fractionation Market Breakdown, by Application
- 10.1.1.5.3 Italy: Europe Plasma Fractionation Market Breakdown, by End User
- 10.1.1.6 Rest of Europe:
Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Plasma Fractionation Market Breakdown, by Product
- 10.1.1.6.2 Rest of Europe: Europe Plasma Fractionation Market Breakdown, by Application
- 10.1.1.6.3 Rest of Europe: Europe Plasma Fractionation Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Plasma Fractionation Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Bharat Serums and Vaccines Limited (BSV)
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bio Products Laboratory Ltd.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Biotest AG.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 CSL Limited
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Grifols, S.A.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Kedrion S.p.A
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Octapharma AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Sanquin
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 SK Plasma
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For Europe Plasma Fractionation Market
